PFM
TMO icon

Privium Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

Privium Fund Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-500
Closed -$257K – 128
2023
Q2 		$257K Hold
500
– – 0.07% 69
2023
Q1 		$288K Sell
500
-820
-62% -$462K 0.1% 61
2022
Q4 		$735K Hold
1,320
– – 0.28% 40
2022
Q3 		$682K Sell
1,320
-1,017
-44% -$569K 0.25% 54
2022
Q2 		$1.27M Buy
2,337
+1,087
+87% +$598K 0.42% 39
2022
Q1 		$738K Buy
+1,250
New +$718K 0.16% 75

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Privium Fund Management's TMO Position: Q3 2023 in Review

Privium Fund Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 500 shares — an estimated $257K sold.

Privium Fund Management first reported a position in TMO in Q1 2022 and held it in 6 quarters. The position peaked at $1.27M in Q2 2022. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Privium Fund Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Privium Fund Management sold 500 Thermo Fisher Scientific shares in Q3 2023, an estimated $257K.
  • Privium Fund Management first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 6 quarters.
  • Privium Fund Management's Thermo Fisher Scientific position peaked at $1.27M in Q2 2022.
  • 2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Privium Fund Management's 13F filing for Q3 2023, filed 6 Nov 2023.